| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Avadel Pharmaceuticals Plc (AVDL) has 6 insiders with recent SEC Form 4 filings, including 6 buys and 5 sells. AVDL is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 115.1K | - | - | |
| Dir | 22.0K | - | - | |
| Dir | 22.0K | - | - | |
| Dir | 11.0K | - | - | |
| Dir | 0 | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 18, 2019 | Glass Geoffrey Michael70 | Director | Buy | 20,000 | $4.99 | $99,800.00 | +32.9% | |
| Nov 15, 2019 | Ende Eric J81 | Director | Buy | 10,000 | $4.98 | $49,762.00 | +35.8% | |
| Nov 15, 2019 | Divis Greg J71 | Chief Executive Officer | Buy | 19,000 | $5.13 | $97,470.00 | +28.3% | |
| Dec 14, 2018 | Kanan Michael F | See Remarks | Sell | 8,429 | $2.49 | $21,021.93 | -22.2% | |
| Dec 14, 2018 | Gusky David P | Controller &CAO | Sell | 617 | $2.68 | $1,655.66 | -13.1% | |
| Dec 14, 2018 | Hatten Sandra L | See Remarks | Sell | 3,173 | $2.58 | $8,183.17 | -7.2% | |
| Aug 10, 2018 | Anderson Michael S | Chief Executive Officer | Sell | 16,297 | $4.91 | $79,953.08 | -6.1% | |
| Aug 10, 2018 | Hatten Sandra L | See Remarks | Sell | 6,290 | $4.91 | $30,858.74 | -12.5% | |
| Jun 26, 2018 | Kanan Michael F | See Remarks | Buy | 1,967 | $5.70 | $11,211.90 | +5.5% | |
| Jun 26, 2018 | Anderson Michael S | Chief Executive Officer | Buy | 2,500 | $6.04 | $15,100.00 | +1.0% |